Notably, the transfer of CART19-28z SNX9 KO was accompanied with increased serum levels of anti-tumor effector molecules IFNγ, Perforin, and Granulysin, while we detected a decrease in IL10 and IL6 (Fig. 5d, Supplementary Fig. 10c, human CCL5 could not be detected in the serum). The gene discussed is GNLY; the disease is neoplasm.